Please login to the form below

Not currently logged in
Email:
Password:

Ian Read

This page shows the latest Ian Read news and features for those working in and with pharma, biotech and healthcare.

Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows

Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows

We are fortunate to have D. Gottlieb join Pfizer’s Board of Directors,” said Pfizer executive chairman and former CEO Ian Read.

Latest news

More from news
Approximately 1 fully matching, plus 54 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    1. Albert Bourla - Pfizer’s new chief executive. The first entry in our alphabetical list is Albert Bourla, who stepped into the shoes of long-serving Pfizer chief executive Ian Read

  • The Orkambi blame game The Orkambi blame game

    CEO Ian Read and AstraZeneca’s Pascal Soriot about the former’s hostile takeover bid in 2014 being the only similar example from recent history.

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Bourla was revealed as CEO in early October, after current boss Ian Read announced he would step down from the role after eight years of service. ... Bourla said: “We are at a pivotal moment in Pfizer’s history, with Ian Read having positioned the

  • Pharma deals continue to slide Pharma deals continue to slide

    At the beginning of the month this was confirmed by Ian Read, CEO of Pfizer. ... During the second quarter earnings call Read said: “We look at BD (business development) as a way of improving returns for shareholders.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Pfizer names Albert Bourla as COO Pfizer names Albert Bourla as COO

    vaccines. Ian Read, chairman and CEO, Pfizer, said: “Albert is a proven and trusted leader with over two decades of leadership experience and a demonstrated track record for delivering strong business

  • Pfizer strengthens board of directors Pfizer strengthens board of directors

    Ian Read, Pfizer's chairman and chief executive officer, said: “We are pleased to welcome Ron Blaylock to Pfizer's board of directors.

  • IFPMA appoints director general IFPMA appoints director general

    Ian Read, IFPMA's president and chief executive and chairman of Pfizer, said: “Thomas has extensive experience in the research-based biopharmaceutical industry and a deep understanding of what is needed

  • IFPMA elects Pfizer’s Ian Read as president IFPMA elects Pfizer’s Ian Read as president

    Read succeeds Merck KGaA’s Dr Stefan Oschmann for a two-year term. ... The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) has elected Pfizer's Ian Read as its new president, succeeding Merck KGaA's Dr Stefan Oschmann.

  • Adobe CEO joins Pfizer board Adobe CEO joins Pfizer board

    The addition of Shantanu Narayen to our board helps ensure that Pfizer will continue to benefit from a diversity of experience,” said Ian Read, Pfizer's chairman and CEO.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
The concordance conundrum: creating space for open dialogue
Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...
Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...

Infographics